Dec 24, 2019 14:22:53 UTCHouston Alerts ALERTHOUSTONAsthma Air Aware Day12-24-2019The Houston Health Department is notifying you that today is a Houston Asthma Air Aware Day. Houston Asthma Air Aware Days occur when outdoor air conditions are similar to days when Houstonians historically experience a high number of asthma problems. Houstonians with asthma should…
Patients with brain tumours are motivated to participate in clinical trials involving repeat tissue sampling. Normalising the use of neoadjuvant and staged surgical trials necessitates…
This cross-sectional study examines the number of vacation days taken per year and the magnitude of physician work while on vacation and their association with…
This cross-sectional study examines the number of vacation days taken per year and the magnitude of physician work while on vacation and their association with…
Dr. Vivek Subbiah, drug development chief at the Sarah Cannon Research Institute, discusses medical advances to treat cancer and search for a cure. Dr. Erika…
Current evaluation of treatment response in solid tumors depends on dynamic changes in tumor diameters as measured by imaging. However, these changes can only be…
Driving Precision Oncology in India 🚀 We are proud to confirm Sewanti Limaye, MBBS, MD, MS, Director of Medical & Precision Oncology at Sir H.…
OncoInfluencers to Follow on Social Media: Dr. Vivek Subbiah / cancer, cancer therapeutics, cancer treatment, drug development, LinkedIn, MD Anderson Cancer
McIntyre et al. demonstrate in an analysis of 1,360 patients the key features of early-stage pancreatic ductal adenocarcinoma (PDAC), including an enrichment of KRASG12R disease that…
Project Optimus, spearheaded by the US FDA’s Oncology Center of Excellence, represents a paradigm shift in the approach to oncologic drug development.1-3 The guidance emphasizes…
View all available purchase options and get full access to this article. The following protocol information is provided solely to describe how the authors conducted…
